Healthcare -
Biotechnology - NASDAQ - US
$ 21.93
1.2 %
$ 3.16 B
Market Cap
-7.95
P/E
DNLI - TOTAL CURRENT ASSETS
Total Current Assets DNLI - Denali Therapeutics Inc.
1.06 B
LAST VALUE
8.90%
2 YEAR CAGR
17.22%
5 YEAR CAGR
0.00%
10 YEAR CAGR